Pharmacovigilance, just like drug development, is an iterative process where all stakeholders work proactively and collaboratively to ensure a systematic approach to safety monitoring. The industry is transitioning to more active safety surveillance activities, creating greater demands for more comprehensive and innovative approaches. Today, AI and machine learning are being viewed as providing potential insights for enhancing patient safety. While still early in usage, AI is demonstrating the feasibility to predict potential issues, further enhancing patient safety in clinical trials.
Join this webinar to learn how AI is transforming clinical development and enhancing patient safety.